Stay updated on BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial page.

Latest updates to the BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedRevision label updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision history updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.1%

- Check44 days agoChange DetectedNo significant changes detected; core study information remains the same.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded a new site revision tag: Revision: v3.4.2, and removed the older Revision: v3.4.1 along with a government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedAdded a site-wide notice about funding-related data delays with links for status updates. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check66 days agoChange DetectedAdded a 'Show glossary' option and introduced a 'Last Update Submitted that Met QC Criteria' field along with a 'Revision: v3.4.0' label. The previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

Stay in the know with updates to BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial page.